Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
The primary vascular dysregulation syndrome: implications for eye diseases.
Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death.
Evoked potentials in multiple sclerosis.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Cognition and eye movements: assessment of cerebral dysfunction.
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Does Slowed Processing Speed Account for Executive Deficits in Multiple Sclerosis? Evidence From Neuropsychological Performance and Structural Neuroimaging.
C-11Utility of the Ten Item Personality Inventory (TIPI) in Multiple Sclerosis (MS): What Can 10 Items Tell Us?
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Pages